Spyre Therapeutics (SYRE) Shares Issued (2015 - 2022)

Spyre Therapeutics' Shares Issued history runs 8 years deep, the most recent figure standing at $10.1 million for Q4 2022.

• Quarterly Shares Issued rose 53.26% year-over-year to $10.1 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $10.1 million (up 53.26% YoY) and the FY2022 annual result came in at $10.1 million, up 53.26% from the prior year.
• Shares Issued was $10.1 million for Q4 2022 at Spyre Therapeutics, up from $6.6 million in the prior quarter.
• Across five years, Shares Issued topped out at $5.4 billion in Q4 2020 and bottomed at $3.1 million in Q4 2018.
• A 5-year average of $1.1 billion and a median of $6.6 million in 2021 frame the typical range for Shares Issued.
• Annual changes were most pronounced in 2020 — Shares Issued surged 137662.54% — and 2021, when it tumbled 99.88%.
• Spyre Therapeutics' Shares Issued stood at $3.1 million in 2018, then rose by 23.75% to $3.9 million in 2019, then jumped by 137662.54% to $5.4 billion in 2020, then tumbled by 99.88% to $6.6 million in 2021, then surged by 53.26% to $10.1 million in 2022.
• Business Quant data shows SYRE's Shares Issued at $10.1 million in Q4 2022, $6.6 million in Q4 2021, and $5.4 billion in Q4 2020.